Garo H. Armen - 15 Feb 2024 Form 4 Insider Report for AGENUS INC (AGEN)

Role
Chairman and Chief Executive Officer, Director
Signature
/s/Christine M. Klaskin, as Attorney-in-Fact for Garo H. Armen
Issuer symbol
AGEN
Transactions as of
15 Feb 2024
Net transactions value
+$324,050
Form type
4
Filing time
15 Feb 2024, 18:59:48 UTC
Previous filing
12 Feb 2024
Next filing
27 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGEN Common Stock Purchase $324,050 +500,000 +397% $0.6481 625,969 15 Feb 2024 See footnote F1, F2
holding AGEN Common Stock 1,231,514 15 Feb 2024 Direct
holding AGEN Common Stock 579,000 15 Feb 2024 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Open market purchases occurred at a weighted average price of $0.6481 (range of $0.6173 to $0.6525).
F2 Shares are held in Dr. Armen's IRA accounts.
F3 Dr. Armen is trustee and has investment authority for the Garo Armen 2020 2 Year AG GRAT holder of 479,000 shares of our Common Stock. Dr. Armen is a general partner in Pixie Partners, a General Partnership ("Pixie"), which as of the date of this report owns 100,000 shares of our Common Stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Pixie and disclaims beneficial ownership to the extent of his pecuniary interest therein.

Remarks:

Chairman and Chief Executive Officer